Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Laura M. De Castro, MD
Healthcare Provider Director for Clinical Translational Research
Sickle Cell Disease
Research Center of Excellence
5115 Centre Ave., 2nd Floor
Pittsburgh, Pennsylvania, United States
Laura M. De Castro MD, MHSc, is an Associate Professor of Medicine and Director of Benign Hematology for the Institute for Transfusion Medicine and UPMC Cancer Center. In addition, she is a hematologist specializing in sickle cell disease and other hemoglobinopathies. Dr. De Castro also serves as Clinical Director of the Benign Hematology Program at UPMC, and works to expand clinical programs in hemostasis and thrombosis.
Dr. De Castro received her medical degree from the Universidad Autónoma de Santo Domingo in the Dominican Republic. She completed her Internal Medicine Residency at the Montefiore Medical Center, Albert Einstein School of Medicine in New York, and her hematology/oncology fellowship at Yale University in New Haven, CT.
Representative Publications:
Morbidity associated with sickle cell disease in pregnancy
Surgical and obstetric outcomes in adults with sickle cell disease
Factors associated with survival in a contemporary adult sickle cell disease cohort
Related Content
-
Sickle Cell Disease Association of North TexasSCDA Tarrant is committed to providing m...
-
A Comparison of an Individualized and Weight-Based Opioid Protocols for the Treatment of Vaso-Occlusive Episodes in ...Introduction: Vaso-occlusive episodes ar...
-
Theodore Wun, MD, FACPDr. Wun graduated from the Albany Medica...
-
Melanie E. Fields, MD, MSCIDr. Fields practices in the Division of ...
-
Opioid management strategy decreases admissions in high-utilizing adults with sickle cell diseaseBackground: A subset of adults with sic...
-
California Institute For Regenerative Medicine Awards City Of Hope $5.74 Million For Severe Sickle Cell Disease Clin...The California Institute for Regenerativ...
-
Grant Recipient Uses Mobile Device Observation in Sickle Cell Pain StudyTechnology takes center stage in a new...